Inactive Instrument

Lucira Health, Inc.

LHDX

US54948U1051

Lucira Health, Inc. Provides Revenue Guidance for the Second Quarter and Third Quarter of 2022

May 12, 2022 at 04:30 pm EDT

Lucira Health, Inc. provided revenue guidance for the second quarter and third quarter of 2022. The company expecting that revenue in the second and third quarters of 2022 may be down sequentially from first quarter.

Latest news about Lucira Health, Inc.

Lucira Health, Inc. Went Out of Business	23-10-04	CI
Anebulo Pharmaceuticals Appoints Daniel George as Part-Time Finance Chief	23-09-29	MT
Lucira Health, Inc. Announces Board and Executive Changes	23-09-25	CI
Lucira Health, Inc. Announces Erik T. Engelson, Chief Executive Officer Resigned from the Position	23-09-25	CI
Lucira Health, Inc. Announces Richard Narido, Chief Financial Officer Resigned from the Position	23-09-25	CI
First Amended Liquidation Plan Approved for Lucira Health, Inc.	23-09-19	CI
First Amended Liquidation Plan Filed by Lucira Health, Inc.	23-09-13	CI
Modified Disclosure Statement Approved on Interim Basis for Lucira Health, Inc.	23-07-28	CI
First Motion for Exclusivity Period Extension Approved For Lucira Health, Inc.	23-07-10	CI
First Motion for Exclusivity Period Extension Filed by Lucira Health, Inc.	23-06-22	CI
Liquidation Plan and Disclosure Statement Filed by Lucira Health, Inc.	23-06-07	CI
Pfizer Inc. acquired Substantially All of the Assets of Lucira Health, Inc.	23-04-19	CI
Motion for Asset Sale Approved for Lucira Health, Inc.	23-04-19	CI
Aditxt's Pearsanta Unit Selected as Backup Bidder to Acquire Lucira Health's Assets	23-04-17	MT
Aditxt Says Unit Pearsanta Submitted Bid to Acquire All of Lucira Health Assets	23-04-17	CI
North American Morning Briefing : Stock Futures -3-	23-04-13	DJ
Asset Purchase Agreement Filed by Lucira Health, Inc.	23-04-12	CI
Pfizer Inc. entered in to an auction to acquire Substantially All of the Assets of Lucira Health, Inc. for $36.4 million.	23-04-09	CI
North American Morning Briefing : Further Caution -2-	23-04-06	DJ
Motion for Asset Sale Approved for Lucira Health, Inc.	23-04-05	CI
Bidding Procedure Approved for Lucira Health, Inc.	23-03-27	CI
Motion for Asset Sale Approved for Lucira Health, Inc.	23-03-24	CI
Lucira Health, Inc.(OTCPK:LHDX.Q) dropped from NASDAQ Composite Index	23-03-03	CI
Motion for Asset Sale Filed by Lucira Health, Inc.	23-03-02	CI
Lucira Health, Inc.(NasdaqGS:LHDX) dropped from S&P TMI Index	23-02-28	CI

Chart Lucira Health, Inc.

Duration

Period

More charts

Company Profile

Lucira Health, Inc. is a United States-based company. The Company has no business operations and is in liquidation.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+111.71%	6.55B
APPLE ISPORTS GROUP, INC.	+98.02%	1.23B
CHURCHILL CAPITAL CORP VII	+2.52%	986M
PERELLA WEINBERG PARTNERS	+14.96%	752M
ARES ACQUISITION CORPORATION II	+2.11%	666M
E7 GROUP	+2.33%	620M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+7.78%	528M
CAPITOL INVESTMENT CORP. VII	-.--%	500M

Shell Companies